Given the higher rates of SA observed among those with AUD, we explored whether there are clinical, genomic, and neurophysiological markers of SA within this population. Among participants diagnosed with an AUD (DSM-IV alcohol dependence) drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), we examined whether clinical risk factors, polygenic scores (PGS) for comorbid psychiatric problems, and neurocognitive functioning differed between those who have and have not reported a lifetime suicide attempt.
